Bhutani, Tina <br/><br/>
Risk of cutaneous squamous cell carcinoma after treatment of basal cell carcinoma with vismodegib.  [electronic resource] 

 -  Journal of the American Academy of Dermatology  Oct 2017 
 - 713-718 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1097-6787 
<br/><br/><label>Standard No.: </label>10.1016/j.jaad.2017.03.038  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Age Factors<br/>Aged<br/>Aged, 80 and over<br/>Anilides--therapeutic use<br/>Antineoplastic Agents--therapeutic use<br/>Carcinoma, Basal Cell--drug therapy<br/>Carcinoma, Squamous Cell--epidemiology<br/>Clinical Trials, Phase I as Topic<br/>Clinical Trials, Phase II as Topic<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Neoplasms, Second Primary--epidemiology<br/>Office Visits--statistics & numerical data<br/>Pyridines--therapeutic use<br/>Retrospective Studies<br/>Risk Factors<br/>Sex Factors<br/>Skin Neoplasms--drug therapy